OTLK

OUTLOOK THERAPEUTICS INC (OTLK)

US
$ 1.744.19%

Price Chart

Key Statistics

Market Cap
$ 82.71M
P/E Ratio
0.47
Revenue (TTM)
$ 5.85M
Volume
586.05K
52W High
$ 8.32
52W Low
$ 0.87
Dividend Yield
0.00%
Beta
0.26

Technicals

50-Day MA
1.8762
200-Day MA
2.3376
52 Week High
8.32
52 Week Low
0.87

About OTLK

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Employees
23
Headquarters
Iselin, NJ
CEO
Mr. Lawrence A. Kenyon CPA

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96